Menopause Hormone Therapy (HRT) in Indianapolis, IN

Bioidentical hormones in Indianapolis: what it means

Behind the label "bioidentical hormone replacement therapy" is a plain idea: a hormone whose structure matches the body's own. Estradiol, the main estrogen the ovaries make before menopause, and micronized progesterone both fit that description. Both come in FDA-approved prescription forms, from estradiol pills, patches, gels and vaginal forms to progesterone capsules.

Many products sold as "bioidentical hormones" or "BHRT" are compounded instead: mixed by a pharmacy for one prescription, often as a custom cream or a pellet. None of these is FDA-approved, and the FDA has not reviewed them for safety, effectiveness or quality before sale. The FDA also says it has no evidence that they are safe and effective, or more effective than approved hormone therapy. A 2020 National Academies review found no rigorous evidence of their safety and effectiveness.

You do not choose a "bioidentical" product from a menu: after a private intake, a physician licensed in Indiana decides what, if anything, fits, and the form. VevaMD does not offer pellets. Since the pharmacy that fills these prescriptions also compounds, ask whether yours is an FDA-approved product or compounded. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

For its size, Indianapolis is well supplied with OB-GYNs: the NPI registry lists 274, or 31.1 per 100,000 residents, against 17.8 for the US and above Indiana's 16.3. That is about 380 women aged 45 to 64 for each OB-GYN in the city, a ratio rather than a count of open appointments.

Counting the area around it, 275 OB-GYNs practice in Indianapolis or within 10 miles and 475 within 25 miles: 26.1 for every 100,000 of the 1,822,697 people who live within 25 miles, a dense supply. Whether or not you have an OB-GYN, you can ask a physician licensed in Indiana about menopause hormone therapy online from Indianapolis, with no waiting room.

Then there are pellets, implanted under the skin at a clinic; compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG recommends FDA-approved menopause hormone therapy over compounded hormones.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11